21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Validation of the Erlangen Score Algorithm for the Prediction of the Development of Dementia due to Alzheimer's Disease in Pre-Dementia Subjects.

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In previous studies, a dichotomous stratification of subjects into "cerebrospinal fluid (CSF) normal" and "CSF pathologic" was used to investigate the role of biomarkers in the prediction of progression to dementia in pre-dementia/mild cognitive impairment subjects. With the previously published Erlangen Score Algorithm, we suggested a division of CSF patterns into five groups, covering all possible CSF result combinations based on the presence of pathologic tau and/or amyloid-β CSF values.

          Related collections

          Author and article information

          Journal
          J. Alzheimers Dis.
          Journal of Alzheimer's disease : JAD
          IOS Press
          1875-8908
          1387-2877
          2015
          : 48
          : 2
          Affiliations
          [1 ] Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, and Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.
          [2 ] Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
          [3 ] Department of Psychiatry and Psychotherapy, Charité Berlin, Berlin, Germany.
          [4 ] Department of Psychiatry and Psychotherapy, Georg-August Universität Göttingen, Göttingen, Germany.
          Article
          JAD150342 NIHMS831067
          10.3233/JAD-150342
          5127395
          26402007
          20e7e536-7d4a-4fec-bab7-3aa7dda4a3f9
          History

          Alzheimer’s disease,biomarkers,cerebrospinal fluid,clinical neurochemistry,results interpretation,validation

          Comments

          Comment on this article